(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 4.1% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Sanofi's revenue in 2025 is $50,740,000,000.On average, 6 Wall Street analysts forecast SNY's revenue for 2025 to be $64,090,147,093,553, with the lowest SNY revenue forecast at $61,757,846,566,626, and the highest SNY revenue forecast at $66,916,843,958,461. On average, 6 Wall Street analysts forecast SNY's revenue for 2026 to be $68,787,143,455,832, with the lowest SNY revenue forecast at $65,722,334,063,665, and the highest SNY revenue forecast at $71,646,859,611,789.
In 2027, SNY is forecast to generate $72,023,540,490,910 in revenue, with the lowest revenue forecast at $64,063,247,632,086 and the highest revenue forecast at $76,978,879,553,947.